WHO-GMP pathway assessment
Review GMP status, dossier gaps, CoA evidence, and destination requirements before regulated trade.
Learn MoreExplore pharmaceutical products across therapeutic areas
Quality-scored products from verified pharmaceutical suppliers
The trust layer for pharmaceutical trade
Supplier and buyer workflows are checked against country-specific regulatory requirements. WHO-GMP, SFDA, NMPA, DRAP, and other credentials are validated where applicable.
Funds held in escrow until quality-gated milestones are met. Payment releases only after CoA verification and shipment confirmation.
Every supplier has a real-time Composite Quality Score based on batch data, deviations, CoA accuracy, and delivery performance.
Built-in regulatory pathway guidance for WHO Prequalification, SFDA, NMPA, and EMA. Compliance documentation generated automatically.
Country-specific workflows for supplier readiness, raw-material import, and export documentation.
Review GMP status, dossier gaps, CoA evidence, and destination requirements before regulated trade.
Learn MoreA stage-by-stage import workflow: supplier documents, DRAP clearance, port testing, and post-market obligations for active ingredients and raw materials from any origin.
Learn MoreGenerate Certificates of Pharmaceutical Product (CoPP), GMP certificates, and Free Sale documents, matched to each destination market’s requirements.
Learn MoreBrowse quality-scored products, APIs, TCM import pathways, and verified suppliers. Filter by drug, dosage form, certification, or trade route.
Submit an RFQ with your volume, destination, and timeline. Multiple manufacturers respond competitively.
Compare offers side by side. Review CQS scores, certifications, and compliance documents.
Escrow-protected payment with quality-gated milestones. Full shipment tracking included.
PMX-verified pharmaceutical suppliers and exporters
The pharmaceutical manufacturing sector spans established generic and branded medicine producers serving regulated and growth markets across the Middle East, Africa, Central Asia, and Southeast Asia. Demand for affordable, quality-assured medicines continues to grow as buyers seek competitive pricing, reliable supply, and verifiable quality standards.
Despite this growth, the sector faces persistent challenges in international markets and raw-material sourcing: inconsistent regulatory compliance documentation, fragmented quality assurance systems, difficulty navigating country-specific requirements (WHO-GMP, SFDA, NMPA, EMA, DRAP), and limited transparent pricing mechanisms. Buyers and importers often struggle to verify supplier credentials, batch quality data, API documentation, and shipment eligibility.
PMX Pharma Exchange bridges these gaps by providing a compliance-linked marketplace where suppliers maintain a real-time Composite Quality Score (CQS), certifications are independently validated, and transactions are protected through escrow services. By combining regulatory technology with B2B commerce, PMX enables pharmaceutical buyers and suppliers to trade with verifiable quality credentials and transparent pricing.
Common questions about pharmaceutical sourcing on PMX